HEALTH● LOWJul 1 · Jul 1, 2026, 6:37 PM
AOB Pharma and Biorasi to Partner to run Phase 2b in Moderate to Severe Acne
nynewsly · united states of america
Following encouraging earlier-phase clinical data, the Company is advancing its acne trial ahead of schedule while maintaining atopic dermatitis global Phase 3 timeline. CAMBRIDGE, Mass., July 1, 2026 /PRNewswire/ — AOB Pharma, Inc. (“AOBiome”), a leading clinical-stage biotechnology company focusing on inflammatory skin conditions, announced that it has partnered with Biorasi, a Clinical Research Organization [...]
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapunited states of america and nearby eventsMore from united states of americaLatest stories and threat level
More in Health
HEALTH31m agoNHIA finances emergency childbirth care for 90,000 women in 18 months — OfficialPremium TimesHEALTH32m agoRisk of Ebola spread in UK is low, experts stressThe TelegraphHEALTH1h agoEbola: A’Ibom Health Commissioner Tasks DSNOs On Heightened SurveillanceChannels TVHEALTH1h ago'Feels like being hit by a bus': Rib remodelling beauty surgery on the riseFrance 24 [en]